IPM Magazine

, Volume 05

Website Content from This Issue

Dark Side of the Genome: Noncoding Mutations in Regulatory Regions of the Cancer Genome to Altered Gene Expression

Researchers in the lab of Trey Ideker

Cost Conscious

DNA Dollars

Learning the Literature: Genomenon, Veritas Collaborate on Next-Gen Publication Prioritization Engine

The Genomenon-Veritas Collaboration will leverage machine learning and artificial intelligence to help create a literature prioritization engine with the promise of more accurate and cost-efficient variant interpretation.

Resolution Revolution: Single-cell Sequencing Techniques Provide Significant Advances

Microscopic view of animal cell.

Wrangle Over DTC Results: Ambry Study Highlights 40% False Positives

A recent study led by Ambry Genetics found that rates of false positives among direct-to-consumer genetic tests was as high as 40%.

AI Influencing Precision Medicine but May Not Match the Hype

Artificial Intelligence concept

10 U.S. Startups to Watch

[Source: a-r-t-i-s-t / Getty Images]

Sanford Health to Power Genomic Cancer Care at Ireland’s Hermitage Medical

Business people shaking hands in conference room

Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis

Rheumatoid Arthritis Isolated on White Background

Metabolon to Profile Samples of Million Veteran Program Participants

'Stalwart' Soldiers in Afghanistan

Exposure to Cold Spurs Epigenetic Changes in Fat Cells

Fat cells, illustration

Richard Williams Leaves Grail to Head Oncology Program at WuXi NextCODE

UCSF Researchers Release Gene-Drug Interaction Map for Precision Chemotherapy

Doctors attending patients receiving intravenous infusion in hospital

Thermo Fisher Unveils International Childhood Oncology Network

Young girl with hair chemotherapy hair loss

CellMax Life, IncellDx to Jointly Market and Develop CTC-based Liquid Biopsy Diagnostics

Woman donating blood

Curetis MDx Test for Lower Respiratory Tract Infection Wins FDA Clearance

Curetis plans to launch its Unyvero System (pictured) and Unyverso Lower Respiratory Tract Infection (LRT) Application Cartridge in the U.S. this quarter after the FDA granted the molecular diagnostic a De Novo clearance. [Curetis]

Wave to Use Deep Genomics’ AI Platform in Drug Discovery Collaboration

Wave Life Sciences will use Deep Genomics’ machine learning-driven biomedical platform to discover novel therapies for treating genetic neuromuscular disorders. Wave is already assessing a Duchenne muscular dystrophy (pictured) candidate in a gklobal Phase I study.[Courtney Young

Angle Enrolls First Patient in Trial of Parsortix CTC Liquid Biopsy

Angle said it has enrolled the first patient for its ANG-002 clinical study

Congenital Heart Defects in Offspring Elevate Maternal Cardiac Disease Risk

Heart disease,Heart disease center

Gene Deletion May Aid Stroke, Spinal Injury Recovery

Genetic engineering, GMO and Gene manipulation concept. Hand is inserting sequence of DNA.

CMS Proposes Coverage for Thermo Fisher Scientific NSCLC Diagnostic

Inside Precision Medicine